Sign in

CIK 0001133869 · Non-accelerated filer<br>Smaller reporting company

CAPRICOR THERAPEUTICS, INC.

Sign in to watch
Ticker
CAPR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(310) 358-3200
Business address
10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
Former names
Nile Therapeutics, Inc., SMI PRODUCTS INC
  1. 4 Open-market sale EVP, GENERAL COUNSEL sold 24,100 shares at $30.38 ($732,158)
  2. 4 Open-market sale CHIEF FINANCIAL OFFICER sold 24,100 shares at $30.38 ($732,158)
  3. 4 Open-market sale EVP, GENERAL COUNSEL sold 900 shares at $30.00 ($27,000)
  4. 4 Open-market sale CHIEF FINANCIAL OFFICER sold 900 shares at $30.00 ($27,000)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Option exercise CHIEF FINANCIAL OFFICER acquired 3,000 shares (option exercise)
  8. 4 Option exercise Director acquired 3,937 shares (option exercise)
  9. 4 Planned sale EVP, GENERAL COUNSEL sold 25,000 shares at $31.70 ($792,548)
  10. 4 Planned sale CHIEF FINANCIAL OFFICER sold 25,000 shares at $31.70 ($792,540)
  11. 4 Planned sale Director sold 7,529 shares at $32.00 ($240,928)
  12. 4 Planned sale EVP, GENERAL COUNSEL sold 25,000 shares at $30.12 ($752,935)
  13. 4 Planned sale Director sold 115,000 shares at an average $30.57 ($3,515,468)
  14. 4 Planned sale CHIEF FINANCIAL OFFICER sold 25,000 shares at $30.13 ($753,153)
  15. 4 Option exercise EVP, GENERAL COUNSEL acquired 2,500 shares (option exercise)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 1 of 18 · 345 filings